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ABSTRACT
Polymicrobial biofilms contain multiple microbial species encased in an extracellular
polymeric matrix. Synergistic interactions within polymicrobial biofilms contribute to elevated
antibiotic resistance and chronic infections; furthermore, prevention and treatment is still an
unresolved issue. The yeast Candida albicans and the Gram positive bacterium Streptococcus
mutans are biofilm-forming oral pathogens that interact mutualistically, and were investigated in
this work. Crystal violet-based biofilm formation assays were used to measure the effect of extracts
from Rhamnus prinoides (gesho), an East African plant used in traditional medicine, on biofilm
formation. The biomass of dual species biofilms was 70% greater than single-species biofilms,
indicating a synergistic interaction. Treatment with gesho extracts reduced both single-species and

polymicrobial biofilm biomass by more than 90% relative to controls. Imaging by epifluorescence
microscopy supported the findings of the biofilm formation assays. In conclusion, gesho exhibited
significant potential for use as an anti-biofilm agent and warrants further investigation.
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1
1.1

BACKGROUND AND SIGNIFICANCE

Biofilms
Biofilms are complex microbial communities (Stacy, McNally, Darch, Brown, &
Whiteley, 2016). They are microbial cells encased in an extracellular polymeric matrix
composed of proteins, carbohydrates and extracellular DNA. Biofilms are found to be
different from planktonic cells in their different regulation of some of their genes as well as
their slow growth rates. The matrix-stabilized environment within biofilms is beneficial for
organisms to communicate with each other through quorum sensing as well as transfer of
genetic material. Biofilms are most commonly found attached to surfaces to which they
cannot easily detach, such as medical devices and pipes in water systems (Donlan, 2002).
Biofilms can be beneficial or detrimental, depending on where they form and their
inhabitants. For example, environmental biofilms are essential in the operation of wastewater
treatment facilities. On the other hand, medical biofilms are the major cause of infections and
persistent diseases (Bjarnsholt, 2013).
Biofilm communities are how bacteria survive in different environments (Høiby et
al., 2011), their ability to overcome stressful conditions increased their persistence and made
them a major cause of nosocomial infections, 50 % of nosocomial infections are related to
indwelling devices such as catheters, dentures and heart valves (Roy, Tiwari, Donelli, &
Tiwari, 2017). Biofilms comprised of pathogens can cause chronic infections. Cystic fibrosis
pneumonia, device associated infections and chronic wound infections are the most common
disease caused by biofilms that can lead to several deaths cases. The severity of infections
caused by biofilms and their ability to be chronic is due to their high resistance to antibiotics
and their ability to resist and evade the immune system (Bjarnsholt, 2013).
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Biofilm treatment has been very difficult and the most effective method is removal of
infected area such as the implant or the organ if possible, but in cases where that is not
possible the main approaches are by combined antibiotic intake before the biofilm formation
or by chronic intake of antibiotics in case the biofilm has already been formed (Bjarnsholt,
2013).
1.2

Polymicrobial Biofilms
Biofilms are often comprised of multiple species and are referred to as polymicrobial
biofilms and can include both prokaryotic and eukaryotic microorganisms (Peters, Jabra-rizk,
Costerton, & Shirtliff, 2012). The human body being complex, harboring the human
microbiota including bacteria, fungi and archaea lead to the presence of polymicrobial
biofilms that has become the more common feature of pathogenic biofilms. Polymicrobial
biofilms display a complex environment that can be altered by various changes of host such
as immunity. Therefore, the study of pathogenic biofilm should be expanded to have a more
in-depth view of the polymicrobial biofilms (Nobile & Johnson, 2016).
Polymicrobial communities help biofilms become more antibiotic resistant through
passive mechanisms; for example, where one organism uses the other’s resistance
.

capabilities to protect itself, a concept referred to as indirect pathogenicity (O’Connell et al.,
2006) Moreover, members of polymicrobial biofilms enhance their quorum sensing
communication as well as increase their metabolic products and the genetic pool where they
will have access to wider variety and more diverse resources (Wolcott, Costerton, Raoult, &
Cutler, 2013). It has been demonstrated that polymicrobial biofilms were not only formed
from multiple bacterial species, but eukaryotic pathogens were involved as well. This
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emphasizes the importance and necessity for increasing attention towards these biofilms and
focus on their essential role in chronic infections (Harriott & Noverr, 2011)
1.3

Antibiotic resistance of biofilms
Several features of polymicrobial biofilms contribute to their enhanced antibiotic

resistance. One important factor is the polymeric matrix surrounding the microorganisms, which
acts as a protective shield against both the immune system of the host and antimicrobial
medications. Prolonged treatment with various antibiotics can cause resistance through exposure
to selective pressure , in addition it allows biofilm bacteria to adapt and acquire resistance
through horizontal gene transfer (Fux, Costerton, Stewart, & Stoodley, 2005). Other mechanisms
have been suggested for biofilm antimicrobial tolerance such as the phenotypic heterogenicity of
cells within the biofilm which is directly related to unequal susceptibility to antimicrobial effects
(Fux et al., 2005).
Stewart and Costerton (2001) hypothesized three mechanisms whereby biofilms are
resistant to antibiotic treatments. Their first hypothesis was the inability of antibiotic molecules
to diffuse through the biofilm matrix to deep layers of bacteria, they added that while some
antibiotics can penetrate through the biofilm, the pace of penetration is highly limited when the
antibiotics are deactivated by bacterial cells in the surface layers of the biofilm. On the other
hand, the development of anaerobic layers with high pH differences between the biofilm layers
due to oxygen consumption in surface layers and metabolic waste product accumulation can
contribute to deactivation to antibiotic activity. The last hypothesis is the formation of a resistant
spore like phenotype by a subpopulation of bacterial cells in the biofilm (Stewart & William
Costerton, 2001). The significance of biofilms in chronic infections and antibiotic infections has
lead to more research focus on prevention and treatment of biofilm communities.
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1.4

Novel approaches for treating biofilms
Several methods have been under trials in effort to develop biofilm treatments. Among

those methods are coating devices with antimicrobial agents to prevent the attachment of
organisms to their surfaces and hinder their growth into biofilms. Other methods include quorum
sensing inhibitors, bacteriophage therapy, oral drug combinations and new antimicrobial agents.
Quorum sensing inhibitors proved to have significant antibiofilm effects but the need for further
research on their safety as well as the debate on their inability to kill cells and only inhibiting
their virulence has stood in the way of their emergence. Bacteriophage therapy concentrate on
targeting bacteriophage to bacterial biofilms and thus removing the biofilm. Bacteriophage
therapy is one of the recently studied mechanisms due to their safety and cost-effective
production. Oral drug combination including quorum sensing inhibitors, enzymes, antifungals,
herbs and antimicrobial agents have been investigated but the safety of such treatment is yet to
be confirmed. Finally development of antimicrobial such as tigecycline have been under study
for their biocidal effects on biofilm associated bacteria with promising effects (Savini et al.,
2010).
1.5

Streptococcus mutans biofilms
Streptococcus mutans is a primary cause of dental carries, due to its ability to form

biofilms in the oral cavity tissue. S. mutans produces adhesins that helps it to bind to the tooth
surface as well as other proteins that help in its biofilm formation S. mutans biofilm formation
mechanisms can be sucrose dependent or independent (Sug Joon Ahn, Ahn, Wen, Brady, &
Burne, 2008). The ability of S. mutans to form robust biofilms lies in the secretion of an
exoenzyme called glucosyltransferase. Through this exoenzyme, S. mutans utilizes sucrose
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supplied from food to produce EPS. Moreover, S. mutans has the ability to overcome stressful
and highly acidic environments, enabling it to survive and form biofilms leading to dental carries
(He et al., 2017).
1.6

Candida albicans biofilms
Candida albicans represent the most common human fungal pathogen that can form

biofilms. According to in vitro studies Candida forms biofilms in several stages. It starts with an
early phase, where it goes through morphogenesis after adhering to a suitable surface. Formation
of hyphae at this stage is essential for Candida to form biofilms. The second stage is the
intermediate stage where hyphae continue their growth with the production of the extracellular
matrix. Finally, the third stage is maturation where the yeast forms are present at the base with
the hyphae at the surface of the biofilm and embedded in the polysaccharide matrix. Candida
infection can be fatal, and studies are focused on their formation on abiotic and biotic surfaces,
for example catheters and oral cavity (Harriott & Noverr, 2011).
Candida species were found to be the main pathogen causing infection for denture users
leading to denture stomatitis. Candida albicans were found to be the most common among the
Candida species. C. albicans can grow in different morphological forms as yeast or
pseudohyphae or true hyphae. The elongated hyphae form has been observed to help the yeast
penetrate into tissue by escaping from phagocytic cells. The ability of C. albicans to form
biofilms through interaction with surfaces and formation of extracellular matrix is dependent on
its ability to form hyphae (Pereira-Cenci et al., 2008).
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1.7

S. mutans and C. albicans polymicrobial biofilms
Fungal and bacterial cooperation in biofilm formation synergizes biofilm activity and

growth. They collaborate with each other to exchange metabolites or growth factors. For
example, S. mutans metabolizes sucrose to glucose and fructose which can be a benefit for C.
albicans (Kim et al., 2017).
Candida albicans or Candida species were found to be the main pathogen causing
infection for denture users leading to denture stomatitis, bacteria were also found to be a factor in
biofilm formation in dentures. Another example of fungal- bacterial association in biofilms is in
the early-childhood caries ECC. Streptococcus mutans is a main bacterial pathogen for dental
caries, especially in early-childhood caries (ECC). It was found that S. mutans is not solely
present but Candida albicans were common in cases of highly infected plaque biofilms with S.
mutans in children with ECC. S. mutans and C. albicans biofilms are enhanced by increase of
exopolysaccarides by C. albicans and hence increasing the biomass. When animals were
coinfected, biofilm virulence was synergized. In vitro studies shows that glucosyltransferase EPS
derived was a main mediator in development of the dual specious biofilms and that C. albicans
enhance the virulence genes expression in S. mutans (Falsetta et al., 2014).
1.8

Rhamnus prinoides (Gesho)
Rhamnus prinoidis is a plant that belongs family rhamnaceae. R. prinoides known as

Gesho was found in Ethiopia and has been widely cultivated.
It was also found in Africa in the south countries like Kenya. The plant has an edible fruit
and has been used for many medicinal treatments such as infectious diseases. It is known for its
ethnomedicinal uses and its parts were used to treat nose, ear and throat infections in kenya while
the leaves are used for tonsillitis in Ethiopia. In addition, gesho has been used in different case of
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scabies, dandruff and hepatitis. Its decoction was used to treat stomach pain and was used in
rheumatism and pneumonia as well. It’s root extract was used for rheumatism and gonorrhea.
Gesho has been studied for its antimicrobial activities and showed positive results that
encouraged its study against diseases (Amabye, 2016; Molla, Nedi, Tadesse, Alemayehu, &
Shibeshi, 2016)

2

RATIONALE

Rhamnus prinoides or gesho is a traditional plant used in East Africa for the treatment of
a variety of infections. Gesho has been found to have a biocidal effect on planktonic cells of
Gram- positive and Gram-negative bacteria, with the more potent effect on Gram positive
species (Molla et al.2016). Our laboratory has found that gesho successfully prevented
Staphylococcus aureus and Bacillus subtilis biofilm formation (unpublished data). Through
preliminary research it was found that gesho has similar inhibitory effects on Streptococcus
mutans biofilm formation. These findings led to the development of the research question that is
the basis of this thesis: “what is gesho’s effect on fungal and bacterial polymicrobial biofilms?”.
Polymicrobial biofilms of S.mutans and Candida albicans demonstrated enhanced biofilms with
increased biomass compared to biofilms of single species (Falsetta et al .2014).The association
of C. albicans with S. mutans in the human oral cavity biofilms and their co-presence that plays a
role in dental carries and denture infections makes them an economically significant model for
the study of gesho on polymicrobial biofilms.
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2.1

Hypothesis
It is hypothesized that gesho extracts can prevent the formation of polymicrobial biofilms

by S. mutans and C. albicans.
2.2

Aim
The aim of this study is to quantitatively test the effect of Rhamnus prinoides extracts on

polymicrobial biofilms comprised of C. albicans and S.mutans. This will be achieved through
testing the activity of Rhamnus prinoides toward the following:
1- S. mutans biofilms.
2- C. albicans biofilms.
3- Polymicrobial biofilms of C. albicans and S.mutans grown together.
The gesho extracts to be tested are gesho stem ethanol extract (GSE), gesho leaf ethanol
extract (GSE), gesho stem water (GSW) and gesho leaf water (GLW). Each extract will be tested
at several concentrations ranging from 0.25 mg/ml to 7 mg/ml.

3
3.1

METHODS

Biofilm formation assays:

3.1.1 S. mutans biofilms
Formation of in vitro biofilms was done in a 96- well microtiter plate, using 0.5% sucrose
to assist S. mutans in biofilm formation (Kunze et al., 2010). Biofilms were grown overnight at
37 ⁰C aerobically on shaker (Sang Joon Ahn & Burne, 2007). The biofilm assay was done using
BHI broth media for growth of S. mutans. S. mutans were cultured from -80 ⁰C stocks in BHI
broth and culture was grown overnight at 37 ⁰C. The following day, the culture concentration
was measured at OD 600 and adjusted to 0.01 to be used in biofilm assay. BHI- sucrose media
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was used for biofilm assay, the BHI-sucrose was filter sterilized before adding S. mutans and
proceeding with the assay. Gesho extracts were prepared at assigned concentrations and added to
96-well (100 µL per well) and the plate was set for overnight incubation at 37 ⁰C on shaker. The
next day, the 96-well plates were washed and stained by crystal violet. Than using 95% ethanol,
biofilms were de-stained to measure absorbance using MD plate reader at an optical density
(OD) of 595 nm (O’Toole, 2011). The experiment was repeated at least three times
independently.
3.1.2 C. albicans biofilms
C. albicans were grown on a 96-well plate according to Pierce et al (2015) with slight
difference, using 1x10⁷ cells instead of 1x10⁶ cells by using hemocytometer cell counting and
calculation. When using hemocytometer, C. albicans was stained by 0.1% v/v methylene blue.
C. albicans was cultured on yeast peptone dextrose (YPD) agar plate overnight at 37 ⁰C form -80
stock. Then a loopful of colonies were cultured in 25 ml of YPD broth for 14-16 hours at 30⁰C
were C. albicans grows as budding yeast. Then C. albicans cells were centrifuged and washed
twice with PBS and adjusted to 1x10⁷ cells using hemocytometer. For biofilm formation in 96well plates, cells were added to RPMI buffered with 165mM morpholinepropanesulfonic acid
(MOPS) (Pierce et al., 2015). The RPMI-MOPS were filter sterilized before C. albicans addition.
Once C. albicans was added to RPMI-MOPS, gesho extracts were prepared at different
concentration of 7,5,3,1,0.5 and 0.25 mg/ml to test its biofilm inhibition effect on C. albicans
biofilms. Only GSE and GLE were tested with C. albicans. Biofilms were stained by crystal
violet after washing the plates than measure absorbance by MD plate reader at OD 595 (O’Toole,
2011).
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3.1.3 Dual species biofilm
The in-vitro growth of the polymicrobial biofilms were done similar to (de Oliveira et al,
2017) but with some changes. Biofilms of S. mutans and C. albicans will be grown using the
same growth media used before for each. BHI/sucrose for S. mutans and RPMI-MOPS for C.
albicans using equal volumes of each media (100 µL) with the same initial concentration used
for each organism (0.01 OD for S. mutans and 1x 107 for C. albicans). Gesho ethanol extracts
were tested at 3 mg/ml. The polymicrobial assay 96-well plate design included S. mutans, C.
albicans and their dual species biofilms untreated compared to their treated counterparts at 3
mg/ml. The plates were washed and stained for reading as done previously. The biofilm biomass
for the nontreated biofilms and the synergistic effect of adding the organisms together surpassed
the MD plate reader reading limit, therefore a 1:10 dilution of the nontreated biofilms were done
before reading and then multiplied by the dilution factor 10 before plotting the data into graphs.
3.2

Viability assays
These assays were done for each extraction after each biofilm assay, the aim is to test the

effect of gesho on the planktonic cells in the suspensions of each well for each fraction. This is
done as part of the effort for understanding the plants’ mechanism for biofilm formation
inhibition. Supernatant of cells from control nontreated cells as well as the 7,5 and 3 mg/ml were
extracted from wells to be tested. Each fraction was diluted 1:10 dilutions from 10-1 to 10-⁷.
Using petri dishes divided into 8 quadrants for the dilutions, each quadrant inoculated with two
drops of 10 µL each. Plates were incubated at 37⁰C overnight. Dilutions showing the least
number of colonies were counted and the data plotted on excel sheet to calculate log reductions
in comparison to the control plate.
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3.3

Polymicrobial Biofilms images

3.3.1 Flow cell biofilm growth system
To view and image the biofilms they were grown via flow cell system. The flow cell was
done according to (Niu et al., 2013) but with few changes to fit our work. The main parts of the
flow cell consist of the flow cell slide covered with glass cover slips which are glued using
silicon, forming chambers to allow flow of media. The flow cell slide has two adjacent channels
through which the media is pumped from the reservoir bottles and circulated for 24 hours at a
rate of 0.9 ml/min at 37 ⁰C. The coverslips serve as surface for biofilm attachment. The entire
system is pre-sterilized through autoclaving and bleaching. Two media reservoirs were prepared.
First one for control with no gesho extracts was prepared with 25 ml of Sucrose/BHI broth with
S. mutans at 0.01 OD as initial concentration, added to 25 ml of RPMI/ MOPs with C. albicans
to reach a total of 50 ml. The second reservoir bottle was prepared like the first one with addition
of GSE extract at a 3 mg/ml concentration. Each bottle was connected to a separate flow cell
slide and they were incubated simultaneously for 24 hours at the same flow rate.
3.3.2 Epifluorescent microscope
C. albicans and S. mutans polymicrobial biofilms 2D images were taken using calcofluor
white as a fluorescent dye for Candida and SYTO 9 for nucleic acid staining producing blue
fluorescence under microscope for C. albicans and green for both C. albicans and

S. muatns.

The effect of gesho extracts tested on dual species biofilms will be examined by these images
that will help primarily in viewing its effect on the biofilms in 2D dimensions.
3.3.3 Cell size of C. albicans and S. mutans by image analysis
AmScope 3.7 for digital camera (United states) software, was used to estimate the size of
S. mutans and C. albicans. Epifluorescent or light microscopy images of biofilms collected as
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described above were analyzed. Pixels were converted to µm using the following equation:
[(Length in pixels) * (10000 µm/ cm)]/ [(resolution in pixels/cm) * (magnification)].
Representative images were selected and cell dimensions from a minimum of three images were
evaluated for gesho-treated and non-treated biofilms.

3.4

Molecular analysis

3.4.1 RNA purification and extraction
The expression of the S. mutans glycosyltransferase genes (gtfB, gtfC) was measured
using the protocol of Falsetta (Falsetta et al., 2014) with some modifications. Four biofilm
cultures were prepared for RNA extraction: S. mutans cultivated alone with and without gesho
extract, and dual species biofilms of S. mutans and C. albicans with and without gesho extract.
RNA extraction and purification were done using a Direct-Zol TM RNA MiniPrep kit (Zymo
research, USA). RNA was collected for both planktonic and biofilm cells. After DNase
treatment, the RNA samples were measured for concentration and purity using a NanoDrop
spectrophotometer (Thermo scientific, NanoDrop 2000), then stored at -80 °C. PCR reactions
were performed on RNA samples to ensure the absence of DNA contamination. Genomic S.
mutans DNA was extracted using a ZR Fungal/Bacterial DNA MicroPrep kit (Zymo research,
USA). Genomic S. mutans DNA was used to confirm the primer annealing temperature in PCR
reaction protocol, and to serve as a positive control in cDNA PCR gel electrophoresis. S.
mutans16s rDNA primers were used in the PCR reaction to identify if any DNA was still present
after DNase treatment and S. mutans genomic DNA was used as a positive control. While for
annealing temperature confirmation and cDNA controls, the gtfB, gtfC primers were used for
PCR reactions.
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3.4.2

RT-qPCR
GtfB,C genes primers were ordered according to the primer sequence used by Klein

(Klein et al., 2012). The Super Script III First-Strand synthesis system for RT-PCR (Invitrogen)
was used to convert RNA samples to cDNA. PCR was used to confirm cDNA formation.
Standards will be prepared by adding specific gtfB, gtfC primers to cDNA. SYBR green will be
used for RT-qPCR. Samples concentrations will be measured using qPCR.

3.5

Statistical analysis
Non-parametric (Kuskal-Wallis Test and Median Test) analyses were performed. Cell size

analysis were done using T-Test. Comparisons were done between control (non-treated) and gesho
treated samples. Differences with a p-value < 0.05 were considered statistically significant and are
noted with asterisk (*).
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4
4.1

RESULTS

Effects of gesho extracts on S. mutans biofilm formation
Significant inhibition of biofilm formation for the GLE fraction with gradual increase in

biofilm formation with the decrease in extract concentration. The most significant decrease in
biofilms were at the 3, 5, and 7 mg/ml concentrations. The GLE 7mg/ml showed 90% biofilm
reduction, 5mg/ml showed 80% biofilm reduction and 55 % reduction for 3mg/ml concentration.
GSE assay resulted in similar effects as GLE with an average 90 % biofilm reduction for the 3, 5
and 7 mg/ml concentrations. While for the GSW 50 %, 25 % and 10 % reductions were shown
for the 3, 5 and 7 mg/ml respectively. GLW had minor inhibitory effects with 10 % and 5 %
reductions for the 5 and 7 mg/ml concentrations respectively. Each assay was repeated 3 times
on independent occasions, results were consistent for each fraction concentrations and the
average of the three assays were plotted as percent of control (Fig 1, Fig 2)

percent of control
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Treatment Concentration

Figure 1 Percent of control average results of Gesho Ethanol leaf and stem extract effects on S. mutans,
(*) indicates significant difference (p < 0.05) between treated samples and the untreated control.

15

Percent of control

120
100
80

*

60

*

GLW

40

GSW

20
0

Figure 2 percent of control average of Gesho water leaf and stem extracts on S. mutans biofilms
(*) indicates significant difference (p < 0.05) between treated samples and the untreated control
4.2

S. mutans viability assays
Viability assays for the S. mutans were carried on the 3,5 and 7 mg/ml concentrations

since they represent the concentrations with the most significant effects. When compared to
control; GLE showed average 2 log reductions for the 7mg/ml concentration, 2 log reductions for
5mg/ml and 1.5 log reduction for 3mg/ml. GSE showed an average 3 log reduction for the
7mg/ml compared to its control, 2.5 log reduction for 5mg/ml and 4 log reductions for 3mg/ml.
GSW and GLW showed minor insignificant log reductions for viability assays with the GSW
showing lower reduction than the GLW. Each assay was repeated three times and an average was
plotted revealing the stated results (Figures 3 and 4).
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Figure 3 Viability assay showing log reductions of S. mutans with gesho ethanol extracts.
(*) indicates significant difference (p < 0.05) between treated samples and the untreated control
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Figure 4 Viability assay showing log reductions of S. mutans with gesho water extracts

4.3

Effects of gesho ethanol extracts on C. albicans biofilm formation
Since the goal of our study is determination of gesho extract effects on polymicrobial

biofilms we opted to work with the most effective extracts. From the S. mutans results gesho
ethanol extracts had the significant effects. Hence, we chose to conduct the biofilm formation
assay for C.albicans only on the ethanol extracts of gesho. Results showed significant inhibition
of biofilm formation for the GSE fraction with more consistent results than GLE. The decrease in
biofilms was similar through most of the tested concentrations 0.5,1,3,5 and 7 mg/ml. The GSE
biofilm reduction ranged from 75-65% among those concentrations. GLE assay resulted in
similar effects as GSE with an average 50% biofilm reduction for all concentrations,
0.25,0.5,1,3,5 and 7 mg/ml. Each assay was repeated 3 times on independent occasions and the
average of the three assays were plotted as percent of control (Fig 5 and Fig 6).
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Figure 5 Gesho leaf ethanol extract effect on C. albicans biofilms, (*) indicates significant
difference (p < 0.05) between treated samples and the untreated control
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Figure 6 Gesho stem ethanol extract effect on C. albicans biofilm, (*) indicates significant
difference (p < 0.05) between treated samples and the untreated control

4.4

C. albicans Viability assays
Viability assays for C. albicans showed an increase to nonsignificant decrease in Log

CfU/ml. GSE showed an increase of one log for 7mg/ml, while the 5 and 3 mg/ml concentration
showed a decrease of less than one log. While GLE showed an increase of around one Log for 3,
5 and 7 mg/ml concentrations (Figure 7).
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Figure 7 Viability assay showing C. albicans Log Cfu/ml increase.

4.5

Effects of GSE on C. albicans and S. mutans polymicrobial biofilms.
Gesho stem extract was chosen due to its more consistent results with C. albicans. GSE

had similar inhibitory effects among most concentrations with C. albicans biofilms, while GSE 3
mg/ml was the lowest concentration with highest effect on S. mutans (Figure 8). Therefore, GSE
3 mg/ml was selected to proceed with performing gesho biofilm assays on polymicrobial
biofilms. The design of this assay was performed to compare between polymicrobial biofilms of
C. albicans and S. mutans and their monomicrobial biofilm biomass. Figure 9 shows the
synergism that occurs in polymicrobial biofilms with more than double increase in biofilm
biomass, almost 75%, compared to each organism alone. On the other hand, GSE treatment
result showed significant decrease in biofilm formation when tested on the polymicrobial biofilm
with even more inhibitory effects than each organism alone.
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Figure 8 Effect of GSE on both S. mutans and C. albicans showing 3mg/ml with highest effect on
S.mutans.
10

c

average OD

8
6

a
4

b

2

a

b

GSE SM

GSE CA

c

0
SM NT

CA NT

SM+CA NT

SM+CA GSE

treatments

Figure 9 Effect of GSE 3mg/ml on S.mutans and C.albicans polymicrobial biofilms, each two
similar letters represent a significant difference between each other, p<0.05

4.6

Epi-fluorescent microscope images
When comparing microscope images of S. mutans- C. albicans gesho treated dual species

biofilm to untreated ones, the images indicated that gesho ethanol extracts significantly
decreased the number of cells for both organisms without observing a prominent decrease in
number for one over the other. C. albicans hyphae formation remains the same and is not
affected. The EPS of the biofilms was extremely demolished, and we can only observe scattered

20

cells of C. albicans and S. mutans (Figure 10). The images for untreated biofilms show dense
biofilms with thick layers of C. albicans and S. mutans (Figure 11).

Figure 10 Images of treated Dual Species biofilms of C. albicans and S. mutans, white
arrows pointes at S. mutans cells.

Figure 11 Images of untreated polymicrobial biofilms of C. albicans and S. mutans
showing dense biofilms.

4.7

Cell size measurements results
For each image the size of C. albicans yeast cells, the C. albicans hyphae and S. mutans

sizes were measured. Each image 3-4 measurement were taken, and an average of measurements
was calculated and plotted into graph (Figure 12). We compared non-treated polymicrobial
biofilms to GSE 3 mg/ml treated polymicrobial biofilms. We can see a difference in size
measurements especially with C. albicans hyphae size, which can be an indication that gesho
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might be affecting hyphae formation in C. albicans. And further investigation is required to
confirm this observation.
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Figure 12 Size measurment of nontreated Vs. treated polymicroibial biofilms
, (*) indicates significant difference (p < 0.05) between treated samples and the untreated control
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5
5.1

DISCUSSION

Gesho inhibits S. mutans and C. albicans polymicrobial biofilm formation
In previous studies, gesho leaf extracts demonstrated antibacterial activity specifically

against Gram positive bacteria (Molla et al., 2016). In our laboratory research, gesho also
successfully caused inhibitory effects on Gram positive bacterial biofilms (unpublished data). In
this study, gesho inhibited C. albicans biofilms and polymicrobial biofilms comprised of both C.
albicans and S. mutans. To test the hypothesis, we investigated the effect of gesho extracts on
each organism alone. Through our results we confirm that gesho can inhibit the biofilm
formation of each organism alone. GSE extracts were the most potent in inhibiting the biofilms
of S. mutans, while for C. albicans, GSE and GLE had similar inhibitory effects, although they
were more consistent with GSE. C. albicans biofilm formation inhibition percentages were
similar for GSE at different concentrations, while for S. mutans GSE showed the highest
inhibition with 3 mg/ml. Therefore, when testing polymicrobial biofilms we opted to work with
GSE at 3 mg/ml concentration.
We compared the biomass of the untreated dual species biofilms to the biomass of C.
albican and S. mutans single species biofilms. The results demonstrated a synergism that resulted
in a 70 % biomass increase for the C. albicans and S. mutans dual species biofilm. These data
confirm the previous study results by Falsetta (Falsetta et al., 2014). In their study, they
presented a model which argues that C. albicans enhances the production of glycosyltransferase
enzymes in S. mutans. Glycosyltransferase enzymes transfer sucrose to glucans, a major
component of the EPS, strengthening the S. mutans component of the dual species biofilm and
hence the overall biomass. Gesho stem extracts displayed significant inhibition of C. albicans
and S. mutans dual species biofilm with GSE 3 mg/ml, even with the synergism gained with the
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association of the two organisms together. Unlike previous studies (Amabye, 2016; Molla et al.,
2016), our study started by testing the leaf and stem extracts separately. The stem extracts had a
strong inhibitory effect. Moreover, we focused on using gesho as a natural remedy for
polymicrobial biofilms formation. Few studies focused on natural treatments for polymicrobial
biofilms, one similar study examined the antimicrobial effects of rosemary, a Mediterranean
woody plant, for inhibiting polymicrobial biofilms (de Oliveira et al., 2017).
5.2

GSE extracts: potential mechanisms
S. mutans being a prokaryote and C. albicans a eukaryote, the mechanism by which

gesho extracts inhibit biofilm formation for each organism is assumed to be different. Our
viability assay results for S. mutans revealed significant log reductions compared to untreated
controls, suggesting that gesho ethanol extracts possess biocidal effects, inhibiting biofilm
formation. On the other hand, C. albicans viability assays showed an increase in C. albicans
growth. We observed an increase or no notable change of CFU/ mL in the treated samples versus
untreated samples. We hypothesize that gesho ethanol extracts do not kill C. albicans cells, but
they can be quorum sensing inhibitors, inhibiting biofilm formation.
Images of C. albicans and S. mutans dual species biofilms assisted in exploring the
mechanism by which gesho ethanol extract act. Based on our finding that GSE effected S.
mutans biofilms by 90% compared to 70% for C. albicans, our initial hypothesis was that our
images will display a lower S. mutans biofilms biomass compared to C. albicans biofilm
biomass. Contradictory to our hypothesis, the images displayed a proportionate reduction in
number for both organisms, with no significant reduction of one organism over the other. Our
second hypothesis was related to the previous study model mentioned earlier (Falsetta et al.,
2014). According to this model, gesho bactericidal effects on S. mutans can compromise its

24

ability to produce glucans for EPS formation and hence C. albicans biofilm formation is affected
as well. Our images show a significant decrease in the EPS of the dual species biofilms, which
indicates that gesho can be acting on the exopolysaccharide matrix formation. The mechanism of
action by which gesho inhibits biofilms is still under question and requires further investigation.
5.3

Molecular analysis and future directions

5.3.1 S. mutans molecular analysis
Molecular analysis for genes involved in biofilm formation will enhance our knowledge
on how gesho works. Each organism has its own genes involved in the biofilm construction
process. In polymicrobial biofilms one organism can influence the gene expression of another.
According to the Falsetta model (Falsetta et al., 2014), C. albicans increases the expression of
glycosyltransferase genes (gtfB, gtfC), enhancing the EPS matrix formation. This model plus
previous work by (Mattos-Graner, Napimoga, Duncan, Smith, & Fukushima, 2004) emphasize
the essential role of the gtf genes in biofilm formation for S. mutans. Image analysis indicated a
significant reduction in polysaccharide matrix formation in the treated polymicrobial biofilms.
This observation is in agreement with our hypothesis that gtf expression is reduced by gesho
extract. This hypothesis will be tested in future work. To this end, RNA extraction and
preparation has been started in the laboratory; to date, cDNA has been synthesized.
5.3.2 C. albicans molecular analysis
Further insight into the mechanism of gesho can also be gained by studying other genes
involved in C. albicans biofilm formation. Some studies are focused on such genes (Blankenship
& Mitchell, 2006), which can be potential targets for our future studies, including bcr1 and efg1
(Falsetta et al., 2014). Through our biofilm assays, we confirm that gesho ethanol extracts have
the ability to inhibit biofilm formation for the dual species biofilms of C. albicans and S. mutans
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as well as their corresponding single species biofilms. Through our images, we know that both
organism’s ability to form biofilms is similarly compromised and the EPS biomass is
significantly reduced. Molecular analysis to compare genetic expression with and without gesho
will help understand the mechanism through which it works.
5.3.3 Applications
According to the National Center for Health Statistics, 37 % of children between ages 2-4
in the United States and 2.4 billion people around the world have dental carries. Dental disease
can be difficult to treat and if stay untreated can cause further systemic complications as diabetes
,pneumonia and heart disease (Fernandes, Bhavsar, Sawarkar, & D’souza, 2018). Dental carries
are caused by pathogenic bacteria forming oral biofilms. They have the ability to metabolize
carbohydrates, producing acidic environment and building the EPS matrix that helps binding the
bacteria to each other (Liu, Ren, Hwang, & Koo, 2018). While various methods have been
studied for disruption or prevention of oral biofilms, antibiotic therapy was not one of the
successful methods for biofilm treatment. The EPS matrix forms a barrier against penetration of
antimicrobials, while decreasing antibiotic activity against oral biofilms (Liu et al., 2018).
Numerous novel methods have been investigated for oral biofilm treatment.
Nanoparticles, phage therapy and photodynamic therapy are just to name a few. In spite of the
variety of investigated new techniques, they still lack in vivo studies and their application and
safety is still under question (Fernandes et al., 2018; Liu et al., 2018).
Natural products and plant extracts were proven to exhibit antimicrobial, anti-adhesive
and anti-biofilm activities against oral pathogens (Karygianni et al., 2016). Plants represent a rich
source of novel compounds and chemicals that can be used in pharmaceutical products. An
estimated 500,000 species are present around the world with only 1% studied for their
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phytochemical activity (Palombo, 2011). Herbs, in contrast to synthetic chemical compounds are
a safe source of treatment. Many of which have been used traditionally for medicinal purposes,
one of which is for oral health. Many herbal products are used as antimicrobials, antiinflammatory and analgesics in dentistry (Kumar, Jalaluddin, Rout, Mohanty, & Dileep, 2013).
The increased resistance to antibiotics as well as their adverse side effects in dentistry raised the
need for other treatment options, natural products represented a promising and safe treatment
alternative (Palombo, 2011). Gesho, an African plant, exhibited antimicrobial, anti-biofilm
activity not only against Gram positive bacterial but also against two of the most common oral
pathogens, C. albicans biofilms and S. mutans biofilms. Gesho represents an addition of a
promising herbal treatment against the oral biofilms. It can be a source of natural anti-biofilm
prevention source than can be used in many applications as mouthwashes or tooth pastes.
5.4

Conclusion
The enhanced resistance of biofilms to antimicrobials helps make them major source of

chronic infection. The existence of polymicrobial biofilms increases their strength and their
resistance. Gesho ethanol extracts were found to exhibit biofilm formation inhibitory effect. Its
effect has been demonstrated on both S. mutans and C. albicans as well as their polymicrobial
biofilms. The mechanism by which it prevents their biofilm formation is still not resolved, but
some hypothesis include 1) it exhibits biocidal effects on S. mutans, 2) it has anti-quorum
sensing effects on C. albicans or 3) it has the ability to inhibit formation of the EPS through
different mechanisms.
In our study we show for the first time that gesho stem extracts possess inhibitory antibiofilm effects. We also focus on polymicrobial biofilms that are formed of dual species of yeast
and bacteria. And as part of our study we showed that gesho inhibits yeast biofilm formation as
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well as Gram positive bacteria. Gesho’s traditional use makes its future use in antibiofilm
products applicable, for example toothpaste or mouthwash. Gesho anti-biofilm results make it a
promising antibiofilm agent.
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